We access our intelligent platform that captures, contextualizes, and converts real-world outcomes into measurable impact.
Don’t just run a registry. Run a real-time study that supports access, label expansion, and product iteration — all in one.
Run FDA-ready studies directly from your clinic. No site startup delays. No IRB red tape. Just outcomes that matter – from your own data.
Tie reimbursement to what actually works. Celéri shows what treatments reduce pain, improve mobility, and cut downstream costs.
Join the evidence-as-a-service movement today!
For Med Tech & Pharma
Life science companies – medtech and pharma -seek efficient ways to design studies, collect clinical data, and iterate on innovations. Our platform offers them streamlined research management and connections to qualified investigators. By accelerating evidence generation and providing insights for regulatory and market needs, we help R&D achieve faster, data-driven development.
For Physician Researchers
Private practitioners have the advantage of agility – they can implement novel techniques or trials faster when not bogged down by academic oversight. Our Research Network physicians report that innovation comes from within the practice and that with the right support they can research, document and scale innovative solutions in community settings. Moreover, clinician-researchers publishing investigator-initiated studies from their own real-world data contribute unique, practice‑grounded insights—expanding product knowledge, uncovering new uses or patient subgroups, and enriching the scientific literature with findings rooted in everyday care contexts.
For Payers
Payers rely on RWE with PROs to fill gaps left by randomized controlled trials, gaining insight into how pain treatments perform across diverse, real-world populations and long-term settings—especially where RCTs may exclude patients with comorbidities or broader demographics. By integrating validated PROs into RWE, payers can better manage utilization, structure value-based contracts, and ultimately ensure treatments deliver real-world outcomes that matter to patients, beyond traditional numeric pain scales.
“We have a responsibility to enhance the lives of patients coping with pain and we are going to continue to innovate to meet our commitment.” – Celéri Health President and CEO, Sean McCrossen
